All sites C00-96,D32-33,D42-43,D45-47,D76 688 89.8 1.0 5.9 0.8 2.6
Mouth, pharynx C00-14 15 100.0 - - - -
  Lip C00 2 100.0 - - - -
  Tongue C02 4 100.0 - - - -
  Mouth, other C03-06 5 100.0 - - - -
  Salivary glands C07-08 2 100.0 - - - -
  Pharynx C01,C09-14 2 100.0 - - - -
Digestive organs C15-26 130 78.5 0.3 14.5 1.9 4.8
  Oesophagus C15 3 80.0 - 6.7 6.7 6.7
  Stomach C16 13 87.3 - 6.3 1.6 4.8
  Small intestine C17 2 100.0 - - - -
  Colon C18 44 95.9 - 2.7 - 1.4
  Rectum, rectosigmoid C19-20 18 96.7 - 1.1 1.1 1.1
  Anus C21 2 100.0 - - - -
  Liver C22 9 72.3 - 21.3 4.3 2.1
  Gallbladder, bile ducts C23-24 8 57.1 4.8 26.2 - 11.9
  Pancreas C25 27 43.1 - 43.8 4.4 8.8
  Other digestive organs C26 2 36.4 - 9.1 9.1 45.5
Respiratory organs C30-39 32 68.9 6.2 19.3 1.2 4.3
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 30 68.7 6.7 20.0 1.3 3.3
  Mediastinum, pleura C38 1 33.3 - 33.3 - 33.3
Bone C40-41 1 75.0 - - - 25.0
Melanoma of the skin C43 26 100.0 - - - -
Skin, non-melanoma C44 39 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 5 100.0 - - - -
Breast C50 204 99.6 - 0.3 - 0.1
Female genital organs C51-58 84 96.0 0.7 1.7 0.5 1.2
  Cervix uteri C53 6 100.0 - - - -
  Corpus uteri C54 46 98.7 - - 0.4 0.9
  Uterus, other C55,C58 0 - - 100.0 - -
  Ovary C56 22 89.8 2.8 5.6 - 1.9
  Other female genital C51-52,C57 10 95.9 - - 2.0 2.0
Urinary organs C64-68 37 89.2 - 7.6 0.5 2.7
  Kidney C64 21 86.9 - 10.3 - 2.8
  Bladder and urinary tract2 C65-68 16 92.3 - 3.8 1.3 2.6
Eye C69 1 50.0 - 25.0 25.0 -
Brain, central nervous system C70-72,D32-33,D42-43 28 85.1 - 14.2 - 0.7
Thyroid gland C73 19 99.0 - - - 1.0
Other endocrine glands C74-75 1 50.0 - 50.0 - -
Illdefined or unknown C76,C80 14 50.7 4.3 30.4 2.9 11.6
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 53 77.5 5.6 3.7 2.6 10.5
  Hodgkin lymphoma C81 4 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 27 98.5 - - - 1.5
  Malignant immunoproliferative diseases C88 1 100.0 - - - -
  Myeloma and other plasma cell tumors C90 7 38.2 2.9 29.4 11.8 17.6
  Leukaemia C91-95 10 51.0 24.5 - 6.1 18.4
  Myelodysplastic syndromes D46 2 20.0 10.0 - - 70.0
  Myeloproliferaitive neoplasms D45,D47 4 72.2 5.6 - - 22.2
Not included above
  Carcinoma in situ of the breast D05 14 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 19 100.0 - - - -
  Borderline tumour of the ovary D39 10 100.0 - - - -
  Basal cell carcinoma of the skin 308 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.